✦ LIBER ✦

Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator

✍ Scribed by Gilles Frenette; Roland R. Tremblay; Claude Lazure; Jean Y. Dube

Publisher: John Wiley and Sons
Year: 1997
Tongue: French
Weight: 43 KB
Volume: 71
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19970529)71:5<897::aid-ijc31>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-specific antigen activates sing

Prostate-specific antigen activates single-chain urokinase-type plasminogen activator

✍ Etsuo Yoshida; Sayuri Ohmura; Masahiko Sugiki; Masugi Maruyama; Hisashi Mihara 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 497 KB 👁 1 views

Prostate-specific antigen (PSA) increases in the plasma of patients with prostate cancer, and has therefore been used as a reliable tumor marker. It has been demonstrated that prostate cancer cells over-express urokinase-type plasminogen activator @PA), which plays an important role in tumor invasio

Human kallikrein 2 (hK2), but not prosta

Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells

✍ Mohammad S. Saedi; Zhu Zhu; Kathy Marker; Ru-Shya Liu; Philip M. Carpenter; Harr 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 193 KB

Human kallikrein 2 (hK2) is a secreted, trypsin-like protease that shares 80% amino acid sequence identity with prostate-specific antigen (PSA). hK2 has been shown to be a serum marker for prostate cancer and may also play a role in cancer progression and metastasis. We have previously identified a